Comparison of the Breast Tumor Microenvironment
NCT03165487 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 14
Last updated 2025-08-22
Summary
The goal of the project is to identify a molecular signature of tumor stroma from "normal" adjacent breast tissue obtained prospectively at the time of breast conserving surgery before and after receiving intraoperative radiation therapy (IORT) in subjects that have luminal A and triple negative breast cancer. IORT is considered as being standard of care.
Conditions
- Triple Negative Breast Cancer
- Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions
- OTHER
-
Breast tissue collection
During Breast Conservation Surgery, one sample will be collected before and after IORT.
- OTHER
-
Blood sample collection
Blood will be collected before and after IORT, and at the two week follow-up.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Eileen Connolly, MD · Assistant Professor of Radiation Oncology
Eligibility
- Min Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-28
- Primary Completion
- 2027-12-01
- Completion
- 2027-12-01
Countries
- United States
Study Locations
More Related Trials
-
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging
NCT05809128 ·Status: UNKNOWN
-
Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)
NCT02688803 ·Status: TERMINATED ·Phase: PHASE4
-
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients
NCT03270072 ·Status: ACTIVE_NOT_RECRUITING
-
LAG3 Expression in Triple Negative Breast Cancer
NCT06259162 ·Status: RECRUITING ·Phase: NA
-
Microbiome Immunotherapy Neoadjuvant Assessment
NCT06709651 ·Status: RECRUITING
-
Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy
NCT02212860 ·Status: COMPLETED ·Phase: NA
-
Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm
NCT02266420 ·Status: COMPLETED ·Phase: NA
-
Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
NCT05910710 ·Status: RECRUITING
-
Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy
NCT05846997 ·Status: UNKNOWN
-
Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer
NCT05896865 ·Status: RECRUITING ·Phase: NA
-
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
NCT01514565 ·Status: UNKNOWN
-
Triple-negative Breast Cancer: a New Perspective on Biomarkers
NCT03539965 ·Status: COMPLETED
-
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
NCT07276880 ·Status: RECRUITING ·Phase: PHASE2
-
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
NCT02587663 ·Status: COMPLETED ·Phase: NA
-
Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer
NCT03176979 ·Status: COMPLETED ·Phase: NA
-
Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast
NCT00556907 ·Status: TERMINATED ·Phase: NA
-
Triple Negative Breast Cancer Biomarker Study
NCT01111175 ·Status: COMPLETED
-
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
NCT01276899 ·Status: COMPLETED
-
Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy
NCT06559696 ·Status: RECRUITING ·Phase: PHASE3
-
Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
NCT02326857 ·Status: COMPLETED
-
Neoadjuvant Chemoradiotherapy Compared to Neoadjuvant Chemotherapy for Luminal-Type Locally Advanced Breast Cancer: a Clinical Study
NCT06697938 ·Status: RECRUITING ·Phase: NA
-
Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
NCT01669148 ·Status: COMPLETED ·Phase: NA
-
Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging
NCT01027767 ·Status: COMPLETED
-
Bringing of PET-TDM FDG in the Determination of the Characteristics of Primary Mammary Tumors TrIple Negatives
NCT04226222 ·Status: UNKNOWN